The Drugs Controller General of India has approved the export of India's first Ebola vaccine manufactured by Serum Institute to Uganda, according to official sources on Thursday. The vaccine was developed by Serum Institute in collaboration...
LifeCell, one of India’s leading comprehensive healthcare solutions providers, announced the launch of a revolutionary genetic test – ?TB (Omega TB) in partnership with HaystackAnalytics, a genomics based health-tech startup. The collaboration...
Vicore Pharma Holding AB, a pioneer in the development of angiotensin II type 2 receptor agonists (ATRAGs), launched the pivotal phase of COMPANION, the first clinical investigation of a digital cognitive behavioural therapy (dCBT) for patients....
MaxCyte, Inc., a leading, cell-engineering focused company, and Curamys, a South Korean biotechnology company, announced the signing of a strategic platform license (SPL)...
The Competition Commission of India on Monday said it has approved the proposed deal of Bharat Biotech International Ltd for acquiring shares of Eastman Exports Global Clothing Pvt Ltd through a share purchase agreement...
MapMyGenome, a preventive genomics company, launched its pharmacogenomics solution MedicaMap on December 4, 2022, which analyses an individual's response to medicines based on genetic makeup. Currently MedicaMap analyses 165 plus US-FDA-approved...
Pfizer Inc is investing more than $2.5 billion at its drug-making plants in Belgium and Ireland, gearing up to launch new products it hopes can replace lost revenue as patents expire and COVID-19 vaccine sales decline...
How important is it to have a separate ministry for pharma sector and what are the various measures the industry should take in order to address the various challenges the industry is facing today.
Citeline partnered with CPHI and Informa Markets as a Knowledge Partner for the Pre-Connect Congress and CPhl CEO Round Table during the 2022 edition of CPhI & PMEC India. The online conference of CPhI & PMEC India commenced on 15th November and...
Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA), Diclofenac Sodium Topical Solution USP, 2% w/w....